Capricor Therapeutics
CAPR
#7991
Rank
โ‚น26.09 B
Marketcap
โ‚น570.82
Share price
-4.36%
Change (1 day)
-54.76%
Change (1 year)

Capricor Therapeutics (CAPR) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น11.34 Billion

According to Capricor Therapeutics 's latest financial reports the company's total assets are โ‚น11.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น14.62 B199.11%
2023-12-31โ‚น4.88 B17.95%
2022-12-31โ‚น4.14 B34.75%
2021-12-31โ‚น3.07 B21.5%
2020-12-31โ‚น2.53 B219.46%
2019-12-31โ‚น0.79 B22.57%
2018-12-31โ‚น0.64 B-37.77%
2017-12-31โ‚น1.03 B-18.44%
2016-12-31โ‚น1.27 B19.3%
2015-12-31โ‚น1.06 B23.6%
2014-12-31โ‚น0.86 B152.53%
2013-12-31โ‚น0.34 B15.21%
2012-12-31โ‚น0.29 B309.1%
2011-12-31โ‚น72.58 M-55.81%
2010-12-31โ‚น0.16 B-2.19%
2009-12-31โ‚น0.16 B-45.7%
2008-12-31โ‚น0.30 B-53.88%
2007-12-31โ‚น0.67 B
2006-12-31N/A-100%
2005-12-31โ‚น0.01 M-54.02%
2004-12-31โ‚น0.02 M-44.02%
2003-12-31โ‚น0.04 M3997.79%
2002-12-31โ‚น0 M-89.78%
2001-12-31โ‚น0.01 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Cytokinetics
CYTK
โ‚น128.93 B 1,036.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น0.33 B-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น17.305 T 152,398.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น382.85 B 3,273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น58.19 B 412.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.55 B-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA